Jakub Michal Zimodro
Overview
Explore the profile of Jakub Michal Zimodro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zimodro J, Rizzo M, Gouni-Berthold I
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40005962
Hypertriglyceridemia (HTG) is associated with a residual risk of atherosclerotic cardiovascular disease. Extremely elevated triglyceride (TG) concentrations, particularly due to familial chylomicronemia syndrome (FCS), pose a risk for acute pancreatitis....
2.
Gasecka A, Kaczorowski R, Pomykala K, Kucharski T, Gajewska M, Siwik D, et al.
Platelets
. 2025 Feb;
36(1):2457415.
PMID: 39907204
Coronary artery bypass grafting (CABG) triggers oxidative stress and platelet activation. High acetylsalicylic acid (ASA) dose might mitigate the transient proinflammatory state. We compared the effect of three ASA dosages...
3.
Gasecka A, Sadowski K, Ploch W, Zimodro J, Gabryel L, Pietrasik A, et al.
Kardiol Pol
. 2024 Aug;
82(10):926-934.
PMID: 39177406
Percutaneous coronary interventions (PCI) are the cornerstone of treatment in patients with coronary artery disease, generating substantial costs for the healthcare system. Considerable improvements in PCI technique, stent technology, and...
4.
Zimodro J, Mucha M, Berthold H, Gouni-Berthold I
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065763
Lipid-lowering therapy (LLT) is a cornerstone of atherosclerotic cardiovascular disease prevention. Although LLT might lead to different reductions in low-density lipoprotein cholesterol (LDL-C) levels in women and men, LLT diminishes...
5.
Zimodro J, Gasecka A, Arski P, Schwarz J, Banach M, Gouni-Berthold I
Arch Med Sci
. 2024 Jul;
20(3):1043-1047.
PMID: 39050163
No abstract available.
6.
Rolek B, Blazejowska E, Procyk G, Zimodro J, Gasecka A
Cardiol J
. 2024 May;
31(3):496-498.
PMID: 38767064
No abstract available.
7.
Blazejowska E, Zimodro J, Figatowski T, Brzeski A, Dziubich T, Parzuchowski J, et al.
Cardiol J
. 2023 Oct;
30(5):846-848.
PMID: 37822077
No abstract available.
8.
Zimodro J, Mucha M, Chabior A, Gasecka A, Koltowski L
Kardiol Pol
. 2023 Sep;
81(11):1160-1162.
PMID: 37718583
No abstract available.
9.
Gawlik M, Zimodro J, Gasecka A, Filipiak K, Szmit S
Curr Oncol Rep
. 2023 Aug;
25(10):1107-1115.
PMID: 37589940
Purpose Of Review: To provide an update on epidemiology, risk factors, and management of cardiac arrhythmias in oncological patients within the context of the new European Society of Cardiology 2022...
10.
Zimodro J, Gasecka A, Jaguszewski M, Amanowicz S, Szkiela M, Denegri A, et al.
Biomarkers
. 2022 Sep;
27(8):720-726.
PMID: 36083024
Background/context: Heart failure (HF) is a heterogeneous condition characterized by increased morbidity and mortality. Objective: This systematic review and meta-analysis of 19 studies was conducted to evaluate the role of...